Effect of the use of prediagnosis hormones on breast cancer prognosis: MCC-Spain study.

Alonso-Molero J, Gómez-Acebo I, Llorca J, Lope-Carvajal V, Amiano P, Guevara M, Martín V, Castaño-Vinyals G, Fernández-Ortiz M, Obón-Santacana M, Alguacil J, Fernandez-Tardon G, Molina-Barceló A, Marcos-Gragera R, Pérez-Gómez B, Aizpurua A, Ardanaz E, Molina AJ, Rodríguez-Cundín P, Moreno V, Rodríguez-Reinado C, Aragonés N, Kogevinas M, Pollán M, Dierssen-Sotos T

Open source

DOI: 10.1097/gme.0000000000002069
Published: 2022 Nov 1
Container: Menopause (New York, N.Y.)
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/gme.0000000000002069,
  title = {Effect of the use of prediagnosis hormones on breast cancer prognosis: MCC-Spain study.},
  author = {Alonso-Molero J and Gómez-Acebo I and Llorca J and Lope-Carvajal V and Amiano P and Guevara M and Martín V and Castaño-Vinyals G and Fernández-Ortiz M and Obón-Santacana M and Alguacil J and Fernandez-Tardon G and Molina-Barceló A and Marcos-Gragera R and Pérez-Gómez B and Aizpurua A and Ardanaz E and Molina AJ and Rodríguez-Cundín P and Moreno V and Rodríguez-Reinado C and Aragonés N and Kogevinas M and Pollán M and Dierssen-Sotos T},
  year = {2022},
  journal = {Menopause (New York, N.Y.)},
  doi = {10.1097/gme.0000000000002069},
  url = {https://doi.org/10.1097/gme.0000000000002069}
}

RIS

TY  - JOUR
TI  - Effect of the use of prediagnosis hormones on breast cancer prognosis: MCC-Spain study.
AU  - Alonso-Molero J
AU  - Gómez-Acebo I
AU  - Llorca J
AU  - Lope-Carvajal V
AU  - Amiano P
AU  - Guevara M
AU  - Martín V
AU  - Castaño-Vinyals G
AU  - Fernández-Ortiz M
AU  - Obón-Santacana M
AU  - Alguacil J
AU  - Fernandez-Tardon G
AU  - Molina-Barceló A
AU  - Marcos-Gragera R
AU  - Pérez-Gómez B
AU  - Aizpurua A
AU  - Ardanaz E
AU  - Molina AJ
AU  - Rodríguez-Cundín P
AU  - Moreno V
AU  - Rodríguez-Reinado C
AU  - Aragonés N
AU  - Kogevinas M
AU  - Pollán M
AU  - Dierssen-Sotos T
PY  - 2022
JO  - Menopause (New York, N.Y.)
DO  - 10.1097/gme.0000000000002069
UR  - https://doi.org/10.1097/gme.0000000000002069
ER  -

APA

J, A., I, G., J, L., V, L., P, A., M, G., V, M., G, C., M, F., M, O., J, A., G, F., A, M., R, M., B, P., A, A., E, A., AJ, M., P, R., V, M., C, R., N, A., M, K., M, P., & T, D. (2022). Effect of the use of prediagnosis hormones on breast cancer prognosis: MCC-Spain study.. Menopause (New York, N.Y.). https://doi.org/10.1097/gme.0000000000002069

Source records

pubmed · retrieved 2026-09-27T11:53:05.842Z
europe-pmc · retrieved 2026-09-27T11:53:05.857Z